Association of impaired fasting glucose with cardiometabolic multimorbidity: The Kailuan study

Zhihui Guo,Shouling Wu,Mengyi Zheng,Pengfei Xia,Qiuyun Li,Qing He,Zhenqiang Song
DOI: https://doi.org/10.1111/jdi.14316
2024-10-26
Journal of Diabetes Investigation
Abstract:This study focuses on analyzing the association between impaired fasting glucose and cardiometabolic multimorbidity in the Chinese population. Our study confirmed that impaired fasting glucose is a risk factor for cardiometabolic multimorbidity, compared with normal fasting blood glucose, impaired fasting glucose increased the risk of cardiometabolic multimorbidity by 183%, and the risk was higher in women than that in men. Aims/Introduction We investigated the association between impaired fasting glucose (IFG) and cardiometabolic multimorbidity (CMM) in the Chinese population. Materials and Methods We included 119,368 participants, free of diabetes mellitus and cardiovascular disease, who participated in the health examination (2006, 2008, 2010) of the Kailuan Study. According to World Health Organization diagnostic criteria, participants were divided into normal fasting blood glucose (FBG) ( 1.25 (95% CI 1.13–1.37) for myocardial infarction, 1.16 (95% CI 1.07–1.25) for ischemic stroke and 1.06 (95% CI 0.88–1.27) for hemorrhagic stroke. Compared with normal FBG, HRs for risk of IFG for CMM were 2.73 (95% CI 2.48–3.02) in men and 3.86 (95% CI 2.92–5.09) in women. Conclusion IFG was a risk factor for CMM. The effect of IFG on diabetes mellitus was stronger than that on other cardiometabolic diseases. The effects of IFG for CMM differed by sex.
endocrinology & metabolism
What problem does this paper attempt to address?